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Biodegradable Polymeric Fiber Structures
in Tissue Engineering
Kadriye Tuzlakoglu, Ph.D., and Rui L. Reis, Ph.D.
Tissue engineering offers a promising new approach to create biological alternatives to repair or restore function
of damaged or diseased tissues. To obtain three-dimensional tissue constructs, stem or progenitor cells must be
combined with a highly porous three-dimensional scaffold, but many of the structures purposed for tissue en-
gineering cannot meet all the criteria required by an adequate scaffold because of lack of mechanical strength and
interconnectivity, as well as poor surface characteristics. Fiber-based structures represent a wide range of mor-
phological and geometric possibilities that can be tailored for each specific tissue-engineering application. The
present article overviews the research data on tissue-engineering therapies based on the use of biodegradable fiber
architectures as a scaffold.
Introduction
Fibers are the fundamental units of textile and fabrics.They can be directly supplied from nature or produced
from synthetic polymers. Natural and synthetic fibers and
fiber-based structures, so-called biotextiles, have been widely
used for biomedical applications.
Biotextiles have been defined as a ‘‘structure composed of
textile fibers and designed for used in a specific biological
environment (e.g., surgical implant), where its performance
depends on its interactions with cells and biological fluids as
measured in terms of its biocompatibility and biostability.’’1
Polymeric fibers that are used in medicine can be manu-
factured using three main techniques: melt spinning,2 dry
spinning, andwet spinning.3 All of these techniques are based
on an extrusion of a polymer melt or solution. In melt spin-
ning, a molten polymer with a suitable viscosity is extruded
at high pressure and constant rate through a spinneret to form
continuous strands of polymeric fibers. Cooling gases then
solidify the formed fibers. Lubricants and finishing oils are
sometimes applied to the fibers in a spin cell. In the next step,
an initial drive roll, which controls the initial take-up speed,
rolls the fibers. The fibers may undergo subsequent heating
and stretching to give them molecular orientation. Finally,
a special control device takes the fibers up onto bobbins at a
constant speed. A melt spinning technique can be applied to
almost all commercially available biodegradable polymers.
The main disadvantage of this process for biodegradable
polymers is that these polymers can degrade during the pro-
cess because of the melting. In the dry spinning process, a
similar approach is used to produce polymeric fibers. The
main difference between these two processes is that, in dry
spinning, the process starts from a polymer solution where
it is a polymeric melt in melt spinning as described above.
The most important thing to be considered here is find-
ing a suitable and volatile organic solvent for the used
polymer. After the extrusion of the polymer solution through
tiny holes of a spinneret, the heated air or gas stream into the
spinneret zone is used to remove the solvent from the fila-
ments. Finally, the fibers are taken up onto the rolls as
in melt spinning. Wet spinning is the oldest and most com-
plicated method of fiber spinning. As in dry spinning, the
polymer is dissolved in a suitable solvent, but there is no
need for a volatile solvent in this process. The most impor-
tant part of this process is the coagulation bath that the
polymer enters after passing through a spinneret. The bath
reacts chemically to coagulate the polymer, or it draws out
the solvent from the polymer stream so that the filament can
harden. In most cases, the second liquid is aqueous. A main
difference between wet spinning and melt or dry spinning is
that it is spinning into a fluid with a much higher viscosity.
Because of this higher viscosity, higher shearing stress occurs
on fiber surfaces, which introduces high tension into the
filaments. This technique is mainly used for natural poly-
mers, which can not dissolve in a volatile solvent and de-
grade before their melting points.
The final properties of the fibers produced using these
three methods can be controlled using different finishing
methods, for instance stretching4 or drying treatments, with
different solvents.5 In addition to thosemain techniques, some
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special methods such as electrospinning6 and gel spinning7
are used in fiber processing. As we will discuss below, be-
cause of the structural similarity of electrospun polymeric
mats to the natural extracellular matrix (ECM), the electro-
spinning process has attracted a great deal of attention in
scaffold processing for tissue engineering.8 In a brief, this
process is based on the generation of an electrical field be-
tween a polymeric solution (or a polymer melt) placed in a
capillary tube with a small-diameter pipette or needle and
a metal collector. When the electrical field reaches its critical
value, repulsive electrostatic force overcomes the surface ten-
sion of the polymer solution, and a charged jet is produced.
This charged polymeric jet then undergoes a stretching pro-
cess that is accompanied by the rapid solvent evaporation
and results in the formation of long, thin nanofibers. Elec-
trospinning has been used to fabricate nanofibrous struc-
tures from a number of natural and synthetic polymers, such
as collagen,9 chitosan,10 chitin,11 silk fibroin,12 hyaluronic
acid (HA),13 poly(DL-lactide-coglycolide),14 poly(L-lactide)
(PLLA),15 and polycaprolactone,16 among many others.
Within the last few years, these nanofibrous structures have
been used as scaffolds in many different tissue-engineering
applications.
Fiber Structures
Fibers can be manufactured as monofilaments or multifil-
aments; they find, for instance, application as a suture in sur-
gery. Sutures are the oldest and simplest example of textiles
used in medicine. They are made of biodegradable and non-
degradable polymers of natural or synthetic origin. Dexon
(polyglycolide; multifilament), Dexon Plus (polyglycolide,
braided), Vicryl (poly[glycolide-L-lactide]; multifilament),
Maxon (poly[glycolide-cotrimethylene carbonate]; monofil-
ament), Biosyn (poly[glycolide-co-L-lactide-cotrimethylene
carbonate]), and PDS (poly p-dioxanone; monofilament) are
the some examples of commercially available biodegradable
sutures.17,18
For more-complex applications, fibers can also be formed
in three-dimensional (3D) structures such as knitted, braided,
woven, and nonwoven. The orientation of fibers in these
structures may range from highly regular to completely
random. The final structure of the fibers affects the behaviors
of the fibers when they are applied. For example, woven
structures have a more-stable and -porous structure than the
other fiber structures. As a disadvantage, they can be un-
raveled at the edges when they are cut squarely or obliquely
for implantation. Knit structures have an inherent ability to
resist unraveling when cut and are flexible and porous, but
sometimes their flexibility is reduced when additional yarns
are used to interlock the loops to obtain more-stable struc-
tures. Additionally, difficulties in reducing their high po-
rosity below a certain value is another clear disadvantage for
some applications. Braided structures are mostly used as
sutures. They can be designed using several different pat-
terns, with or without a core. The spaces between the yarns,
which cross each other, make them porous and help the fluid
flow during the healing process. Non-woven structures may
have a wide range of porosities. Their isotropic structure
provides good mechanical and thermal stability. They can
easily compress and expand. These advantages make them
a suitable material for many tissue-engineering applications.
Applications in Tissue Engineering
Tissue engineering offers a promising new approach to
create biological alternatives for regenerating different tis-
sues. It typically involves the use of stem or progenitor cells
seeded in a scaffold, which can guide the cell growth and
tissue formation in three dimensions. Several requirements
must be considered in the design of tissue engineering scaf-
folds, including high porosity, large surface area, adequate
pore size, and uniformly distributed interconnected porous
structures throughout the matrix.19–21
Biodegradable polymeric fiber structures can provide a
large surface area and a large porosity (except electrospun
ones), which can be optimized for specific applications. Be-
sides these, many tissues, such as nerve, muscle, tendon, liga-
ment, blood vessel, bone, and teeth, have tubular or fibrous
bundle architectures and anisotropic properties. Therefore,
fiber-based structures find a number of applications in tissue
engineering, including soft tissue repair, vascular prostheses,
bone and cartilage scaffolds, and nerve guides. Alternatively,
many parameters must be considered in the design of fiber
architectures, such as optimal fiber diameter and linear
density, overall porosity and pore size distribution, influence
of fiber orientation on cellular response, and influence of de-
gradation on the properties of the structures.
Soft tissue engineering
Skin replacement. Skin is a complex organ and consists
mainly of a superficial and an inner layer, called the epi-
dermis and dermis, respectively. Most skin wounds can heal
naturally, but replacement becomes a serious problem when
burns, trauma, or disease irreversibly damages the skin. The
most common approach for skin replacement is the use of
autografts or allografts,22–24 but they have many limitations,
including the creation of a donor site, risk of infection, and
slow healing. Over the past 2 decades, tissue engineering
approaches have been studied to construct a 3D skin archi-
tecture using a temporary scaffold combined with fibro-
blasts, keratinocytes, and endothelial cells.25,26 The majority
of tissue-engineered structures used in skin replacement are
freeze-dried biopolymer sponges combined with the above-
mentioned cells. However, freeze-drying is a labor-intensive,
costly process that can produce sponges with significant
structural heterogeneity. In addition, the pore structure and
degree of porosity do not always perfectly allow the nutrient
and oxygen transfer that are important factors in the skin
replacement process. However, fiber-based scaffolds can
overcome these problems by providing a high degree of
porosity and structural integrity with high reproducibility,
although other than the electrospun ones, they still can carry
a risk of having bacterial infection because of their high
porosity.
The use of biodegradable fiber-based structures has been
proposed for healing of dermal or epidermal injuries. Themost
successful fiber-based dermal equivalents are the commer-
cialized products Dermagraft and Dermagraft-TC. Der-
magraft is a structure consisting of fibroblasts, ECM, and a
biodegradable fiber mesh.27 A polyglactin (PLGA) mesh is
used as a scaffold for fibroblasts. The fibroblasts that proli-
ferate into the scaffolds secrete human dermal collagen,
matrix proteins, growth factors, and cytokines and create a
dermal substitute. This has been applied clinically to patients
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with diabetic foot ulcers. It was found that healing was faster
and better in patients with Dermagraft treatment compared
than in control patients (debridement and moist wound
healing).28,29 Dermagraft-TC is a Silastic covered form of
Dermagraft that acts as a nonbiodegradable form because
of the covering. The Food and Drug Administration has
approved its use as a dermal substitute. More recently, the
PLGA knitted mesh has been combined with collagen mi-
crosponges for 3D culturing of skin fibroblasts.30 In this new
hybrid approach, the PLGA knitted mesh serves as a scaffold
to support the forming tissue while collagen microsponges
help new and homogenous dermal tissue formation.
In addition to these commercialized synthetic fiber struc-
tures, natural fibers, such as chitin, chitosan, alginate, and a
benzyl ester of HA (Hyaff 11), are also proposed for wound
healing because of their wound healing ability.31 For instance,
Hirano et al.32 developed a new biocompatible dressing
material made of wet-spun chitin-acid glycosaminoglycan fi-
bers that released a portion of the glycosaminoglycan (GAG)
into the body. Softness and easy handling of these fibers could
be useful in the healing ot epidermal tissue injuries.
Many researchers have studied engineering of dermal
tissue using a nonwoven scaffold based on a benzyl ester of
HA.29,33–35 To obtain a nonwoven mesh structure, hyalur-
onan benzyl ester thread is produced using phase separation
extrusion technology and then cut, carded, and needle-
punched. For instance, Tonello et al.34 studied the coculturing
of fibroblast and endothelial cells into a hyaluronan-based
fiber mesh to create microcapillary-like structures in a der-
mal graft. Such a structure could aid in the healing of deeper
lesions, where tissue vascularization is needed.
Electrospun nanofibrous mats have been also investigated
as a novel wound dressing material. Nanofiber matrices
show high oxygen permeability because of their high surface
area (5–100m2=g), which also allows fluid accumulation at
the wound site.36 Alternatively, their pore size is small en-
ough to prevent bacterial penetration, making them a
promising candidate for wound dressing. For instance, Katti
et al.37 used an electrospinning method to produce antibiotic-
loaded poly(lactide-coglycolide) nanofibrous membranes for
wound healing. Collagen-based electrospun mats were also
studied for using in tissue engineering applications, includ-
ing wound healing.38
Vascular grafts. Biomedical textiles can find an application
in the cardiovascular area, namely as vascular grafts. To
mimic the soft, flexible structure of natural blood vessels, they
have been used in woven, knitted, snf microporous tubular
structures. Early attempts to develop a vascular graft focused
on the use of bypass grafts made of nondegradable or de-
gradable synthetic materials. The most-used nonbiodegrad-
able synthetic polymeric fiber structures for this purpose are
Dacron and Teflon.39–41 Later, fiber structures made of bio-
degradable polymers were applied as temporary scaffolds
for the regeneration of blood vessels. The first proposed to-
tally biodegradable vascular graft was PLGA 910 knitted
mesh (Vicryl) in 1979. Woven polyglycolic acid (PGA)
structures have been also evaluated in a rabbit model as a
vascular graft.42
After many studies based on direct implantation of bio-
degradable grafts, tissue engineering approaches have star-
ted to be applied to the cardiovascular system in the
development of a blood vessel substitute. For example, Kim
et al.43 studied the use of nonwoven PGA matrices, which
were coated with PLLA to eliminate stability lack of PGA
mesh, to design tissue-engineered constructs. The smooth
muscle cells (SMCs) seeded onto these matrices had high
cellular viability and produced a large amount of ECM
proteins. Others have attempted to use surface hydrolyzed
nonwoven PGA scaffolds for culturing SMCs.44 Nonwoven
PGA scaffolds hydrolyzed using strong alkaline conditions
have resulted in the creation of new functional groups (hy-
droxyl, carboxylic acid) and a decrease in fiber diameter. As
a result of both changes in the scaffold, the SMCs seeded on
them exhibit better adhesion capability and more-spread
morphology than untreated PGA scaffolds. The morpho-
logical changes of the cell could be due to the surface func-
tional groups that were not present before surface treatment,
as could the increase in seeding efficiency. In another study,
Shum-Tim et al.45 created a new vascular graft of nonwoven
PGA mesh and biodegradable polyhydroxyalkanoate as an
inner and outer layer, respectively. After 1 week of culture of
a mixed cell population of endothelial cells, SMCs, and fi-
broblasts in these tubular structures, the final construct was
implanted into a lamb. It has been observed that these tissue-
engineered constructs could resemble the native aorta and be
used as vascular substitutes. In a later study, tubular scaf-
folds were designed from nonwoven PGA fabrics coated
with a poly(L-lactide-cocaprolactone) (50=50) porous mem-
brane. The constructs made of these scaffolds and mixed cells
showed no occlusion or aneurysmal formation when they
were implanted in dogs. Moreover, a line of endothelial cells
was observed at the luminal surface of each autograft. More
recently, these scaffolds have been successfully implanted
with bone marrow cells into patients.46
To mimic the natural structure of blood vessels, Xu et al.47
have suggested the use of aligned nanofibrous poly(L-
lactide-co-e-caprolactone) scaffolds produced using electro-
spinning and proposed that these systems be used for blood
vessel engineering. They have reported that nanofibers can
provide aligned attachment migration of SMCs along the
axis of nanofibers In addition, it has been also found that
distribution and organization of smooth muscle cytoskeleton
proteins inside SMCs were parallel to the direction of the
nanofibers.
Stankus et al.48 have proposed one of the most challenging
approaches in blood vessel tissue engineering, which in-
cludes electrospinning and cell microintegration. They have
used an electrospinning process to produce elastomeric tu-
bular conduits form biodegradable poly(ester urethane) urea
while vascular SMCs were microintegrated into these con-
duits using an electrospraying process that runs parallel to
the electrospinning. As a result of this new production of
blood vessel conduits, they obtained homogenous SMC in-
tegration into the electrospun tubular conduits.
Prosthetic heart valves. The other application of biode-
gradable polymeric fibers in the cardiovascular field is the
tissue engineering of heart valves. The clinically available
prosthetic heart valves include xenograft, mechanical, and
homograft valves, but there are limitations to the long-term
benefits of these valve prostheses, such as poor durability,
foreign body reaction, infection, anticoagulation, and donor
scarcity. Many studies have been undertaken to determine
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whether tissue-engineering principles could be used to de-
velop valve tissue substitutes. Seeding of human fibroblasts,
endothelial cells, or marrow stromal cells on biodegradable
fiber mesh is a new approach for the creation of human
autologous tissue-engineered heart valves. PGA nonwoven
scaffolds are the most widely used materials for this pur-
pose.49–51 To improve cell attachment and proliferation, PGA
and PLA nonwoven fiber mesh structures have been coated
with poly-4-hydroxybutyrate and their performance tested
under dynamic conditions.52
Stents. Biodegradable fiber structures have also been pro-
posed for use as stents.53–56 A stent is an expandable mesh
tube that mechanically supports vessels against elastic re-
coil and reduces the restenosis rate in percutaneous coro-
nary interventions.54 Biodegradable stents are used only
when temporary airway stenting is needed. For instance,
paclitaxel-loaded melt-extruded PLLA fibers have been tried
as temporary stents.54 Furthermore, Saito et al.56 studied a
biodegradable knitted stent made using PLLA in rabbit air-
ways. The results have showed that the knitted tubular
PLLA stents could be used like commercially available sili-
cone stents. Nuutinen et al.53 developed a biodegradable stent
from PLLA fibers using a braiding technique. These stents
showed similar radial pressure stiffness as commercial me-
tallic stents. They also studied the mechanical properties and
in vitro degradation of biodegradable knitted stents made of
polylactide, poly(L-lactide-co-D-lactide) and poly(L-lactide-
coglycolide) fibers.55 It has been shown that the different
chemical composition of these fiber structures provided for
different degradation rates, which can be tailored for specific
applications.
Nerve tissue regeneration. The nervous system is a com-
plex, sophisticated system that regulates and coordinates
body activities. It has two major divisions: the central nervous
system and the peripheral nervous system. The central ner-
vous system consists of the brain and the spinal cord, and the
peripheral nervous involves all of the nerves that branch off
from the spinal cord to the extremities. Neurons in the central
nervous system have different characteristics and cannot re-
generate by themselves. Therefore, restoration of their function
is a major challenge in neurology. Recently, engineering of
neural tissue using scaffolds with or without cells has become
an alternative to traditional transplantation methods. For ex-
ample, Yang et al.15 developed highly porous and fibrous
PLLA scaffolds prepared using liquid–liquid phase separation
methods to be used in nerve tissue engineering. These nano-
fibrous scaffolds showed an ability to support nerve stem cell
differentiation and neurite outgrowth.
In the peripheral nervous system, injuries generally affect
axons, which can be regenerated using a variety of methods,
depending on how far the stumps are apart from each other.
To avoid the problems of autografts and allografts, artificial
nerve guidance channels have been developed. A nerve
guide is a conduit that bridges the gap between the nerve
stumps and directs and supports nerve regeneration. Most
nerve guides reported in the literature have a rigid, solid
structure from a number of natural or synthetic polymers
such as collagen,57 alginate=chitosan,58 PLA and PLGA,59 and
polyphosphoesters,60, They are mostly obtained by dipping a
mandrel into a polymer solution several times until an ap-
propriate thickness is achieved. They can then be used di-
rectly or freeze-dried to have porous structures. This method
causes nonelastic final structure, although this can be over-
come with freeze-drying or salt-leaching to achieve a porous
structure. As a result of freeze-drying (or salt-leaching), the
scaffolds created have a heterogeneous pore structure that
does not provide proper guidance for the axons. Recently,
nerve guides based on biodegradable fibers have been stud-
ied. For instance, Bini et al.61 fabricated a nerve guide from
microbraided poly(L-lactide-coglycolide) fibers, which al-
lowed for good nutrient transfer because of its microbraided
structure. They observed successful regeneration in rats after
1 month of implantation. Later, they used the same approach
to produce microbraided chitosan conduits.62 However,
chitosan based conduits did not show the same success as
poly(L-lactide-coglycolide) conduits because of the swelling
characteristic of chitosan. A nerve guide made from poly
(L-lactide-coglycolide) was also fabricated using an electro-
spinning method.63
A nerve guide made of collagen filaments has been pro-
posed as an alternative to the tube-type nerve conduits.64
The collagen conduits consisting of 2,000 collagen filaments
showed better regeneration than collagen tubes (as a control)
in regeneration of rat sciatic nerve. In another study, syn-
thetic biodegradable fibers made of PLLA were examined
using dorsal root ganglia in vitro.65 PLLA filaments oriented
the growth of Schwann cells and neurites along the longitu-
dinal axis of the filament. In addition, better neurite growth
has been observed when the filaments were coated with la-
minin.65 Steuer et al.66 also studied in vitro axonal outgrowth
using polylactide filaments coated with rat Schwann cells.
They demonstrated that axonal outgrowth on polylactide
sheets coated with Schwann cells was 15 times better than
on sheets without Schwann cells.
As another engineering approach, Cheng et al.67 reported
successful axonal regeneration in rats as a result of implan-
tation of a construct consisting of Schwann cells seeded on
PLGA 910 fiber scaffolds and biomembrane.
Hard tissue engineering
Articular cartilage.Articular cartilage of the knee is a highly
specialized connective tissue responsible for cushioning and
lubricating. It is an avascular, aneural, alymphatic tissue that
contains only one cell type, chondrocytes. Because of its
avascular, low cellular nature, the self-healing capacity of
articular cartilage is limited. Various techniques for repairing
cartilage defects have been developed, including abrasion,68
drilling,69microfracture,70osteochondralgrafting,71andtrans-
plantation of tissue-engineered constructs.72–74 Many differ-
ent types of polymeric matrices with and without cells have
been tested in vitro, as well as in experimental animals and in
human patients, for their ability to promote articular carti-
lage repair. Recent trends are toward the use of fiber-based
structures for engineering of articular cartilage. Most bio-
degradable fiber structures used are made using poly-
a-hydroxy acid and HA. In embryonic tissue, hyaluronan is
the main component of ECM and plays an important role in
chondrogenic condensation during limb formation.75 It has
been shown that HA can affect the differentiation of chon-
drocytes,76 although it is difficult to form HA without any
modification, and it can usually be modified using esterifi-
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cation. As was previously described, Hyaff is a derivative of
HA and is being investigated as a scaffold for articular car-
tilage repair. For example, Brun et al.77 have compared Hyaff
7 and Hyaff 11 nonwoven meshes, which have the same fiber
thickness (20 mm) but different in vitro and in vivo degrada-
tion rates. Chicken embryo chondrocytes seeded in both
structures maintained their phenotype and secreted ECM for
up to 3 weeks of in vitro culture. Hyaff 11 nonwoven scaf-
folds with a slower degradation rate promoted a higher cell
proliferation rate. They later reported on the use of Hyaff 11
nonwoven scaffolds as a support for mesenchymal progen-
itor cells that produced the main ECM molecules accompa-
nied by an occasional synthesis of mature type II collagen.78
Moreover, when those structures were implanted in rab-
bit knees, with or without cells, there was no inflammatory
response, and they degraded within 4 months after implan-
tation. Other studies with human chondrocytes and mesen-
chymal stromal cells also confirmed that Hyaff 11 nonwoven
meshes could promote the growth and differentiation of
chondrocytes and production of collagen type II and ag-
grecan; they also down-regulate the production of collagen
type I.79–81
Poly a-hydroxy acid–based fibrous matrices have been
widely investigated to serve as cartilage grafts. For instance,
Freed et al.82–85 have performed several studies in which they
used PGA fiber meshes and freshly isolated chondrocytes to
investigate the influence of scaffold properties, as well as
seeding and culture methods, on the development of carti-
lage constructions. Ma et al.86 have also investigated ways to
engineer cartilage tissue by seeding articular chondrocytes
onto PGA nonwoven scaffolds. They reported that, after the
aggregate modulus of the engineered cartilage reached 179
 9 kPa after 20 weeks of in vitro cultivation, which was 40%
of that of natural articular cartilage.
To provide cells with the ability to suspend and make it
possible to distribute cells within the polymeric mesh, syn-
thetic nonwoven mesh structures have been combined with
some naturally derived materials such as alginate, collagen,
and fibrin. Using this approach, Ameer et al.87 have prepared
a composite, composed of a polyglycolide nonwoven mesh
coated with fibrin gel, for use in meniscal surgery. At 4
weeks of culture, GAG content in fibrin-coated PGA mesh
scaffolds was found to be better than in uncoated PGA mesh
scaffolds. In another similar study, PLGA meshes with two
different compositions (slower-resorbing 47.5=52.5 PGA-PLA
and faster resorbing 90=10 PGA-PLA) have been combined
with chondrocyte-suspended alginate gel and tested in vitro
and in vivo. Both types of coated copolymer pads showed
uniform cell distribution and similar performance regarding
expression of aggrecan, type I collagen, and type II collagen.88
However, the construct consisting of 47.5=52.5 PGA-PLA, al-
ginate, and chondrocytes exhibited better performance when
implanted in osteochondral defects of rabbits. It has also been
shown that alginate stimulates the chondrogenic phenotype of
the transplanted chondrocytes and prevents cells from floating
out of the defects. Other researchers have used type I collagen
for chondrocyte encapsulation and tried to combine this gel
with nonwoven polylactide (PLLA) scaffolds.89 This method
allowed a high number of chondrocytes to be homogeneously
encapsulated into the scaffolds.
More recently, collagen type I has been also used to create
web-like structures within the PLGA knitted meshes to
achieve uniform cell distribution.90 The bovine chondrocytes
seeded on these scaffolds have shown homogenous distri-
bution, maintained their phenotype, and regenerated carti-
laginous matrix, filling the void spaces in the scaffolds. To
obtain thicker scaffolds, the cell–composite constructs have
been laminated or rolled after 1 day of culture and implanted
subcutaneously in the dorsum of athymic nude mice. In vivo
results have demonstrated the formation of articular carti-
lage after 12 weeks of implantation. These new approaches
have promised to generate structurally regular cartilage.
The use of bioreactors is a great challenge to obtain a ho-
mogenous scaffold–cell construct for cartilage and bone re-
generation. Such systems can provide good nutrient transfer
throughout the porosity of the scaffolds, which results in
better cell migration and production of ECM in the interior
part of the scaffolds. These systems have been successfully
applied for creating a tissue-engineered cartilage construct
using fiber-based scaffolds. Davisson et al.91 have reported
the positive effect of perfusion on cell content and ECM
production of bovine articular cartilage cultured PGA scaf-
folds. The synthesis of sulfated GAG has been found to be
40% higher than under static conditions. Griffon et al.92
compared two dynamic culturing techniques for culturing
porcine chondrocytes on a scaffold composed of PGA mesh or
chitosan sponge. A better, more-uniform cell attachment has
been found when PGA scaffolds were used in the vacuum-
reactor system.
Finally, within the last few years, biodegradable nonwo-
ven nanofibers, which are produced using electrospinning,
have started to be used as scaffolds for regeneration of car-
tilage. A 3D matrix made of polycaprolactone nanofibers
with a diameter of 700 nm have been proposed as a scaffold
for cartilage tissue engineering.93 The primary chondrocytes
that were seeded onto these scaffolds proliferated and effi-
ciently maintained their differentiated phenotype, as indi-
cated by the expression of cartilage-associated genes. In a
later study,94 the same authors demonstrated that PCL
nanofibrous scaffolds enhanced the chondrogenic differen-
tiation of human mesenchymal stem cells (MSCs) signifi-
cantly more than the cell pellet culture system, which is a
widely used culture protocol for studying chondrogenesis of
MSCs. Collagen-based nanofibrous scaffolds have also been
proposed for cartilage tissue engineering. Collagen is a nat-
urally occurring polymer and one of the major components
of ECM of animal tissues. It is found in ECM in a fibrillar
form with a diameter of 50 to 300 nm. It has been shown that
collagen type II can be electrospun as a nonwoven mat with
a fiber diameter between 110 nm and 1.8 mm and used as a
scaffold for chondrocyte seeding.95
Bone. Bone is a complex, dynamic, highly vascular tissue
with a large amount of ECM and limited cell population. As
in all tissue engineering fields, many studies96–100 have been
conducted to recreate the complexity, stability, and biologic
function of bone tissue. The most common strategy for en-
gineering of bone is to use a scaffold combined with osteo-
blasts or the cells that can mature or differentiate into
osteoblasts and regulating factors that promote cell attach-
ment, differentiation, and mineralized bone formation.101
The requirements for the design and production of an ideal
scaffold for bone regeneration are complex and not yet
fully understood. It is generally agreed that it must be a
BIODEGRADABLE POLYMERIC FIBER STRUCTURES 21
biocompatible, porous (>90% and pore sizes between 100
and 350 mm), interconnected, and permeable structure to
permit the ingress of cells and nutrients.102 Structures de-
signed with biodegradable fibers can meet all these criteria
and serve as a scaffold for the engineering of bone. Many
different fiber-based polymeric matrices have been tested
with different cell types to create a bone construct. For in-
stance, bone marrow cells seeded in a nonwoven HA poly-
meric scaffold (Hyaff 11) in a mineralizing medium and basic
fibroblast growth factor have shown mineralization through
the expression of the markers Calcium (Ca), alkaline phos-
phatase, osteopontin, bone sialoprotein, and collagen I.103,104
Recently, Mikos et al.96,105 reported a study in which they
used biodegradable fiber mesh scaffolds to create bone
substitutes under dynamic culture conditions. In this study,
rat bone marrow cells were seeded onto nonwoven PLLA
scaffolds with a thickness of 1.7mm, a volumetric porosity of
99%, and a fiber diameter of 17mm.96 These constructs were
cultured in a flow perfusion bioreactor or under static con-
ditions. It was found that nonwoven PLLA scaffolds could
support the attachment, growth, and differentiation of rat
bone marrow cells. Moreover, it has been reported that flow
perfusion could accelerate calcified matrix deposition and
provide a homogenous cell distribution though the inte-
rior part of the scaffold. Gomes et al.105 used the same ap-
proach to culture rat bone marrow cells in starch-based fiber
mesh scaffolds. They observed greater osteogenic differenti-
ation of bone marrow stromal cells when they cultured on
starch-based fiber mesh scaffolds under dynamic conditions.
They also reported that fiber-based structures were more ad-
vantageous than extruded porous structures because of their
highly interconnected structure, which provides homogenous
tissue formation.
We also developed chitosan-based nonwoven structures
as bone tissue-engineered scaffolds using a traditional wet
spinning technique.106 We demonstrated that chitosan non-
woven scaffolds had an ability to support osteoblast cell
attachment.
As a new trend in the tissue-engineering field, nanofibrous
scaffolds produced using an electrospinning process have
been also suggested for bone tissue engineering. For exam-
ple, nonwoven polycaprolactone nanofibrous scaffolds have
been tested with MSCs derived from the bone marrow of
neonatal rats under dynamic culture conditions.16 After 4
weeks of culture, at least the surfaces of the cell–polymer
constructs were covered with cell multilayers. Additionally,
these structures could support mineralization and produc-
tion of type I collagen under dynamic culture conditions.
However, colonization by cells of 3D electrospun scaffolds is
a major problem because of the pore size of the scaffolds,
which is typically less than average cell size. It has been
shown that107 the mean pore radius of electrospun matrices
varies with fiber diameter. For example, a 100-nm fiber di-
ameter yields a mean pore radius of less than 10 nm at a
relative density of 80%. The comparative size of a rounded
cell (ranging from 5 to 20mm) shows that such small pore
sizes will obstruct cellular migration. For a scaffold that re-
quires minimal cellular infiltration (e.g., a vascular graft),
proliferation limited to the surface may be acceptable or even
desirable, but in the case of bone and cartilage, cell migration
throughout the interior part of the scaffold is necessary to
obtain 3D constructs that will create a targeted tissue later
on. Additionally, it was also reported in the same study that
electrospun scaffolds are not truly 3D structures because the
fiber axes may be inclined only a few degrees with respect to
the plane of the network. These 2D networks can be stacked
upon one another and give a thicker scaffold, but the density
of unit area increases with an increasing number of layers,
which will reduce the mean pore size in this approach.
Related to electrospun mats, Li et al.108 have presented the
next step in such nanofibrous PCL scaffolds by culturing
human MSCs that can differentiate into adipogenic, chon-
drogenic, and osteogenic lineages in the same matrix. This
promising result underscores the potential of using stem cells
and nanofibers in bone tissue engineering. More recently,
Jin et al.109 used the electrospinning technique to produce
nanofibrous fiber mats with an average fiber diameter of
700 50 nm from silk fibroin with polyethylene oxide. In vitro
culture studies with human bone marrow stromal cells have
shown that these matrices, especially after polyethylene
oxide extraction, could support initial cell attachment and
ingrowth.
Tuzlakoglu et al.110 suggested a new approach to design-
ing a structure that combines polymeric micro- and nanofi-
bers in the same construct. This novel structure aims to serve
as a scaffold and mimic the physical structure of ECM for
bone tissue regeneration while simultaneously providing the
macro support that cells require. Nano- and microfiber-
combined scaffolds have been produced from starch-based
biomaterials using a fiber-bonding electrospinning two-step
methodology. The cell culture studies with human osteoblast-
like cell line (SaOs-2) and rat bone marrow stromal cells
demonstrated that the presence of nanofibers influenced cell
shape and cytoskeletal organization of the cells on the nano-
and micro-combined scaffolds as well as cell viability and al-
kaline phosphatase activity.
In addition to the use of polymeric fiber structures as a
scaffold, an application for a special kind of bone regenera-
tion in dentistry has also been found, as a membrane for
guided tissue regeneration (GTR). These barrier membranes
prevent epithelial migration and promote the regeneration of
new connective tissue attachment. Vicryl periodontal mesh
and Gore Resolut (composed of polyglycolide fiber and tri-
methylene carbonate) have successfully been used for this
application.111,112 A PLA-coated knitted PGA mesh was de-
veloped and suggested for use as a barrier membrane in
GTR.113 Fujihara et al.114 have developed another GTR
membrane composed of polycaprolactone and calcium car-
bonate using an electrospinning process.
Anterior cruciate ligament. Ligaments are bands or sheets
of fibrous connective tissue between two or more bones and
are responsible for providing motion and stability to joints
and transmitting tensile loads in the musculoskeletal system.
Ligaments consist mainly of collagen fibers that are formed
into large bundles with a specific orientation. The anterior
cruciate ligament (ACL) connects the femur to the tibia and
acts as a primary stabilizer of the knee. A rupture of the ACL
cannot heal, and a surgical reconstruction is required to re-
store normal joint function. Tissue engineering offers a po-
tential technique to design ligament replacement grafts using
a biodegradable scaffold with or without cells. An ideal scaf-
fold for the ACL must provide a high degree of mechanical
strength initially and lose its strength by gradually degrading
22 TUZLAKOGLU AND REIS
while new tissue is remodelling. Because of the natural struc-
ture of the ACL, collagen-based fiber scaffolds are widely
used for ACL replacement.115,116 The mechanical strength
and the control of the rate of degradation of collagen scaf-
folds could be improved by cross0linking for instance with
ultraviolet or carbodiimide.116 However, it has been shown
that both cross-linking methods have different advantages
with regards to final mechanical strength and the corre-
sponding cell attachment. Silk is another natural polymer
that has been proposed for tissue engineering of ACLs.117
When they are properly prepared, silk fiber matrices, which
have good mechanical properties as well as biocompatibility
and slow degradation, can serve as suitable matrices to
support adult stem cell differentiation toward ligament lin-
eages. HA-based fibers are another natural-origin alternative
for ACL replacement. Cristino et al.118 have designed a pro-
totype scaffold with a multilayered knitted cylindrical array
of Hyaff 11 fibers oriented in two directions. They indicated
that MSCs grown on these scaffolds could express collagen
type I, collagen type III, laminin, fibronectin, and actin, which
are the characteristic markers of the ligament tissue.
Alternative biodegradable materials in ACL reconstruc-
tion are the synthetic polymers (polydioxanone, polylactide,
polyglycolide, and their copolymers). These materials have
been proposed as implants for using directly or as scaffolds
for creating 3D tissue-engineered constructs. Based on the first
approach, commercially available polydioxanone has been
suggested for ACL replacement,119 but it degrades quickly,
which can be a problem for this application. It has been re-
ported that polydioxanone loses half of its tensile strength in
approximately 4 to 6 weeks, whereas the process for replace-
ment can take up to 12 months.120 A similar problem has oc-
curred when braided polyglycolide (Dexon) ligaments were
used for replacement. For example, Cabaud et al.121 used
braided polyglycolide (Dexon) ligaments, which showed
828N maximum linear load at 22.6% strain, for the repair of
ACL of dogs. Although they showed high initial strength, their
degradation time was not long enough to protect the repaired
ligament. In a later study, Laitinen et al.122 tested the me-
chanical properties of braided PLLA implants in vitro and after
subcutaneous implantation in rabbits. These implants have
shown better mechanical strength and a slower degradation
rate than polydioxanone and PGA, which would be advanta-
geous for reconstruction of the ACL. Within the last few years,
biodegradable synthetic fibers have been formed into 3D
scaffolds for the engineering of ACLs. Cooper et al. have de-
veloped a new braiding procedure to create 3D scaffolds with
the desired pore diameter, porosity, mechanical properties,
and geometry from different polyesters, namely PLLA, PGA,
and polylactic-co-glycolic acid 82:18 (PLAGA).123,124 Although
PGA scaffolds have shown the highest tensile strength, they
have supported a lower level of ACL cell attachment and
growth than PLAGA and PLA because of their fast degrada-
tion time and released degradation product during cell culture.
Alternatively, fibronectin-coated PLLA scaffolds have pro-
vided for a better cell viability than PGA and PLAGA and
maintained their structural integrity and high mechanical
properties over the culture period.123 These results confirm
that tissue engineering of ACLs using fiber-based scaffolds and
ACL cells is a promising approach for ACL reconstruction.
CONCLUS3Tissue engineering is a new approach that
proposes the regeneration of tissues using stem or progenitor
cells and scaffolds or artificial ECMs. The design of an ideal
scaffold remains a problem in most tissue-engineering fields.
Although it is specific for each tissue, it is generally agreed
that biocompatibility, biodegradability, porosity, intercon-
nectivity, and surface properties are the main requirements
for an ideal scaffold. The fiber-based architectures described
in this review seem to be promising scaffolds for many dif-
ferent tissue-engineering applications because of their highly
porous and interconnected pore structures and their me-
chanical strength and structural integrity combined with
a large surface area, but there are still many issues to be
addressed, including the choice of a proper material, the
combination and diameter of fibers (distinct for different ap-
plications and cell sources), and scaffold geometry for each
specific application.
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